IOSBIO LTD

04497290
Active United Kingdom

Other human health activities

12 employees website.com
Life sciences and medical technology Other human health activities
I

IOSBIO LTD

04497290

Other human health activities

Founded 29 Jul 2002 Active United Kingdom 12 employees website.com
Life sciences and medical technology Other human health activities

Previous Company Names

STABILITECH BIOPHARMA LTD 14 Oct 2016 — 30 Sept 2020
STABILITECH LTD 29 Jul 2002 — 14 Oct 2016
Accounts Submitted 19 May 2026 Next due 30 Apr 2026 2 months overdue
Confirmation Submitted 7 Nov 2025 Next due 19 Nov 2026 5 months remaining
Net assets £6M £969K 2024 year on year
Total assets £8M £1M 2024 year on year
Total Liabilities £2M £2M 2024 year on year
Charges 1
1 outstanding

Contact & Details

Contact

Telephone

0800 000 0000

Website

www.example.com

Full company profile for IOSBIO LTD (04497290), an active life sciences and medical technology company based in United Kingdom. Incorporated 29 Jul 2002. Other human health activities. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Aug → 31 Jul 2024
Type total-exemption-full
Next accounts 31 Jul 2025
Due by 30 Apr 2026 2 months overdue

Balance Sheet & P&L (2014–2024)

Cash in Bank

£1.98M

Increased by £1.07M (+118%)

Net Assets

£5.60M

Decreased by £969.07k (-15%)

Total Liabilities

£2.40M

Increased by £2.08M (+644%)

Turnover

N/A

Employees

12

Decreased by 2 (-14%)

Debt Ratio

30%

Increased by 25 (+500%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Jul Year End
2023
31 Jul Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 3
Grants 3

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

7 Allotments 21,311,406 Shares £5.22m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
30 Jan 202620,052,906£515k£0.026
11 Jun 20241,432£1k£0.81
24 May 2024914,826£741k£0.81
28 Oct 2020198,882£2.30m£11.57
25 Mar 202097,737£1.13m£11.57

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (186)

Cbh Compagnie Bancaire Helvetique Sa
15.5%
725,598
Mark Joseph Irwin
14.9%
695,942

Persons with Significant Control

Persons with Significant Control (0)

0 Active 1 Ceased

Sif Investment Company Limited

Ceased 31 Jul 2020

Ceased

Group Structure

Group Structure

IOSBIO LTD Current Company

Charges

Charges

1 outstanding

Properties

Properties

1 leasehold 1 total
AddressTenurePrice PaidDate Added
Ground Floor And Basement, Hayworthe House, Market Place, Haywards Heath (RH16 1DB) MID SUSSEX
Leasehold-13 Jun 2022
Ground Floor And Basement, Hayworthe House, Market Place, Haywards Heath (RH16 1DB)
Leasehold
Added 13 Jun 2022
District MID SUSSEX

Documents

Company Filings

DateCategoryDescriptionDocument
19 May 2026AccountsAnnual accounts made up to 31 Jul 2025
6 May 2026OfficersTermination of James Wallace Hudleston as director on 6 May 2026
4 Feb 2026CapitalAllotment of shares (GBP 24,734.03) on 30 Jan 2026
7 Nov 2025Confirmation StatementConfirmation statement made on 5 Nov 2025 with updates
11 Jun 2025OfficersChange to director Craig Antony Joseph Laferriere on 11 Jun 2025
19 May 2026 Accounts

Annual accounts made up to 31 Jul 2025

6 May 2026 Officers

Termination of James Wallace Hudleston as director on 6 May 2026

4 Feb 2026 Capital

Allotment of shares (GBP 24,734.03) on 30 Jan 2026

7 Nov 2025 Confirmation Statement

Confirmation statement made on 5 Nov 2025 with updates

11 Jun 2025 Officers

Change to director Craig Antony Joseph Laferriere on 11 Jun 2025

Recent Activity

Latest Activity

Annual accounts made up to 31 Jul 2025

1 months ago on 19 May 2026

Termination of James Wallace Hudleston as director on 6 May 2026

1 months ago on 6 May 2026

Allotment of shares (GBP 24,734.03) on 30 Jan 2026

4 months ago on 4 Feb 2026

Confirmation statement made on 5 Nov 2025 with updates

7 months ago on 7 Nov 2025

Change to director Craig Antony Joseph Laferriere on 11 Jun 2025

1 years ago on 11 Jun 2025